A detailed history of Capital Investment Advisory Services, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Capital Investment Advisory Services, LLC holds 4,640 shares of VRTX stock, worth $1.9 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
4,640
Previous 5,777 19.68%
Holding current value
$1.9 Million
Previous $2.71 Million 20.32%
% of portfolio
0.22%
Previous 0.3%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$460.0 - $505.78 $523,020 - $575,071
-1,137 Reduced 19.68%
4,640 $2.16 Million
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $33,388 - $41,270
-85 Reduced 1.45%
5,777 $2.71 Million
Q1 2024

Apr 25, 2024

SELL
$407.69 - $446.08 $20,384 - $22,304
-50 Reduced 0.85%
5,862 $2.45 Million
Q4 2023

Feb 01, 2024

BUY
$343.0 - $410.68 $40,817 - $48,870
119 Added 2.05%
5,912 $2.41 Million
Q3 2023

Nov 02, 2023

BUY
$338.18 - $362.46 $48,697 - $52,194
144 Added 2.55%
5,793 $2.01 Million
Q1 2023

Apr 21, 2023

BUY
$283.23 - $323.1 $1,699 - $1,938
6 Added 0.11%
5,649 $1.78 Million
Q4 2022

Feb 03, 2023

SELL
$285.76 - $321.48 $9,430 - $10,608
-33 Reduced 0.58%
5,643 $1.63 Million
Q3 2022

Oct 26, 2022

SELL
$273.83 - $305.53 $15,060 - $16,804
-55 Reduced 0.96%
5,676 $1.64 Million
Q2 2022

Jul 22, 2022

SELL
$234.96 - $292.55 $71,662 - $89,227
-305 Reduced 5.05%
5,731 $1.62 Million
Q1 2022

May 03, 2022

SELL
$221.42 - $260.97 $1,549 - $1,826
-7 Reduced 0.12%
6,036 $1.58 Million
Q4 2021

Feb 01, 2022

SELL
$177.01 - $223.45 $74,344 - $93,849
-420 Reduced 6.5%
6,043 $1.33 Million
Q3 2021

Oct 28, 2021

BUY
$181.39 - $202.99 $54,416 - $60,897
300 Added 4.87%
6,463 $1.17 Million
Q2 2021

Jul 27, 2021

SELL
$187.49 - $221.1 $29,998 - $35,376
-160 Reduced 2.53%
6,163 $1.24 Million
Q1 2021

May 05, 2021

BUY
$207.02 - $241.31 $20,702 - $24,131
100 Added 1.61%
6,323 $1.36 Million
Q4 2020

Jan 25, 2021

BUY
$207.01 - $276.09 $654,151 - $872,444
3,160 Added 103.17%
6,223 $1.47 Million
Q3 2020

Oct 19, 2020

SELL
$255.65 - $303.1 $208,866 - $247,632
-817 Reduced 21.06%
3,063 $834,000
Q2 2020

Aug 05, 2020

SELL
$225.48 - $295.8 $16,911 - $22,185
-75 Reduced 1.9%
3,880 $1.13 Million
Q1 2020

Apr 28, 2020

BUY
$199.77 - $247.81 $15,981 - $19,824
80 Added 2.06%
3,955 $941,000
Q4 2019

Feb 04, 2020

BUY
$166.71 - $223.91 $72,852 - $97,848
437 Added 12.71%
3,875 $848,000
Q3 2019

Oct 17, 2019

SELL
$166.23 - $187.09 $8,311 - $9,354
-50 Reduced 1.43%
3,438 $582,000
Q2 2019

Aug 08, 2019

SELL
$164.61 - $190.37 $182,223 - $210,739
-1,107 Reduced 24.09%
3,488 $607,000
Q1 2019

Apr 23, 2019

SELL
$163.73 - $194.7 $102,494 - $121,882
-626 Reduced 11.99%
4,595 $845,000
Q4 2018

Feb 04, 2019

SELL
$151.91 - $192.21 $17,317 - $21,911
-114 Reduced 2.14%
5,221 $865,000
Q3 2018

Oct 30, 2018

SELL
$167.73 - $192.74 $838 - $963
-5 Reduced 0.09%
5,335 $1.03 Million
Q1 2018

Apr 30, 2018

SELL
$151.6 - $177.13 $34,110 - $39,854
-225 Reduced 4.04%
5,340 $870,000
Q4 2017

Jan 31, 2018

SELL
$137.28 - $155.55 $3,157 - $3,577
-23 Reduced 0.41%
5,565 $834,000
Q3 2017

Oct 31, 2017

BUY
$148.13 - $162.24 $827,750 - $906,597
5,588
5,588 $850,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Capital Investment Advisory Services, LLC Portfolio

Follow Capital Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.